Upper limb spasticity resulting from stroke Upper limb spasticity
Conditions
Interventions
instructing amplitude excersize by using automatic jiggling machine
Upper limb spasticity
Sponsors
Abo Masahiro
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Targetting patients with upper limb spasticity as a result of aftereffects of stroke, and who meet all of the following criteria, and who can obtain their consent; 1)Stroke sequelae patients with upper extremity spasticity between the ages of 20 and 80 2)More than 6 months have passed since the onset of stroke 3)Upper limb Brunstrom stage, which is an upper limb function evaluation, is 3-5 4)The general condition is stable 5)Patients who do not recognize cognitive impairment and can understand the research plan 6)Patients who received a sufficient explanation to participate in this study and, after a thorough understanding, obtained the written informed consent of the patient. 7)Regardless of gender 8)Patients who can visit the hospital according to the study schedule
Exclusion criteria
Exclusion criteria: Those who meet at least one of the following exclusion criteria will be excluded. 1)Patients with implantable medical devices (pacemakers or cochlear implants) 2) Patients with serious heart disease 3) Pregnant women or patients suspected of being pregnant 4) In addition, patients who are judged to be inappropriate to participate in this study by research responsible doctors or assigned doctors 5) Patients who are unstable or need immediate treatment (acute heart failure, acute renal failure, acute liver failure, severe diabetes, infectious disease, etc.) 6) Patients who participated in other clinical trials within 4 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of change in upper limb function: Fugel-Meyer Assessment(FMA), between treatment (week 0) to 12 weeks after treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparative evaluation of (1)Modified Ashworth Scale (MAS), (2) Range Of Motion (ROM), (3)Visual Analogue Scale (VAS) , between the start of treatment (0 week, Day 0) to 12 weeks after treatment | — |
Contacts
Public ContactTakuya Hada
The Jikei University Hospital
Outcome results
None listed